List of Tables
Table 1. Continuous Manufacturing in Pharmaceutical Market Trends
Table 2. Continuous Manufacturing in Pharmaceutical Market Drivers & Opportunity
Table 3. Continuous Manufacturing in Pharmaceutical Market Challenges
Table 4. Continuous Manufacturing in Pharmaceutical Market Restraints
Table 5. Global Continuous Manufacturing in Pharmaceutical Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Continuous Manufacturing in Pharmaceutical Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Continuous Manufacturing in Pharmaceutical Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Continuous Manufacturing in Pharmaceutical Product Type
Table 9. Key Companies Time to Begin Mass Production of Continuous Manufacturing in Pharmaceutical
Table 10. Global Continuous Manufacturing in Pharmaceutical Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Continuous Manufacturing in Pharmaceutical as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Continuous Manufacturing in Pharmaceutical Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Continuous Manufacturing in Pharmaceutical Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Continuous Manufacturing in Pharmaceutical Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Continuous Manufacturing in Pharmaceutical Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Continuous Manufacturing in Pharmaceutical Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Continuous Manufacturing in Pharmaceutical Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Continuous Manufacturing in Pharmaceutical Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Continuous Manufacturing in Pharmaceutical Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Continuous Manufacturing in Pharmaceutical Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Continuous Manufacturing in Pharmaceutical Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Continuous Manufacturing in Pharmaceutical Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Continuous Manufacturing in Pharmaceutical Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Continuous Manufacturing in Pharmaceutical Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Continuous Manufacturing in Pharmaceutical Sales Value by Region (2019-2024) & (%)
Table 27. Global Continuous Manufacturing in Pharmaceutical Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Continuous Manufacturing in Pharmaceutical Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Continuous Manufacturing in Pharmaceutical Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Continuous Manufacturing in Pharmaceutical Sales Value, (2025-2030) & (US$ Million)
Table 31. Siemens Basic Information List
Table 32. Siemens Description and Business Overview
Table 33. Siemens Continuous Manufacturing in Pharmaceutical Products, Services and Solutions
Table 34. Revenue (US$ Million) in Continuous Manufacturing in Pharmaceutical Business of Siemens (2019-2024)
Table 35. Siemens Recent Developments
Table 36. Syntegon Basic Information List
Table 37. Syntegon Description and Business Overview
Table 38. Syntegon Continuous Manufacturing in Pharmaceutical Products, Services and Solutions
Table 39. Revenue (US$ Million) in Continuous Manufacturing in Pharmaceutical Business of Syntegon (2019-2024)
Table 40. Syntegon Recent Developments
Table 41. Corning Basic Information List
Table 42. Corning Description and Business Overview
Table 43. Corning Continuous Manufacturing in Pharmaceutical Products, Services and Solutions
Table 44. Revenue (US$ Million) in Continuous Manufacturing in Pharmaceutical Business of Corning (2019-2024)
Table 45. Corning Recent Developments
Table 46. GEA Basic Information List
Table 47. GEA Description and Business Overview
Table 48. GEA Continuous Manufacturing in Pharmaceutical Products, Services and Solutions
Table 49. Revenue (US$ Million) in Continuous Manufacturing in Pharmaceutical Business of GEA (2019-2024)
Table 50. GEA Recent Developments
Table 51. SK pharmteco Basic Information List
Table 52. SK pharmteco Description and Business Overview
Table 53. SK pharmteco Continuous Manufacturing in Pharmaceutical Products, Services and Solutions
Table 54. Revenue (US$ Million) in Continuous Manufacturing in Pharmaceutical Business of SK pharmteco (2019-2024)
Table 55. SK pharmteco Recent Developments
Table 56. Korsch Basic Information List
Table 57. Korsch Description and Business Overview
Table 58. Korsch Continuous Manufacturing in Pharmaceutical Products, Services and Solutions
Table 59. Revenue (US$ Million) in Continuous Manufacturing in Pharmaceutical Business of Korsch (2019-2024)
Table 60. Korsch Recent Developments
Table 61. Chemtrix Basic Information List
Table 62. Chemtrix Description and Business Overview
Table 63. Chemtrix Continuous Manufacturing in Pharmaceutical Products, Services and Solutions
Table 64. Revenue (US$ Million) in Continuous Manufacturing in Pharmaceutical Business of Chemtrix (2019-2024)
Table 65. Chemtrix Recent Developments
Table 66. L.B. Bohle Basic Information List
Table 67. L.B. Bohle Description and Business Overview
Table 68. L.B. Bohle Continuous Manufacturing in Pharmaceutical Products, Services and Solutions
Table 69. Revenue (US$ Million) in Continuous Manufacturing in Pharmaceutical Business of L.B. Bohle (2019-2024)
Table 70. L.B. Bohle Recent Developments
Table 71. Pharmira Basic Information List
Table 72. Pharmira Description and Business Overview
Table 73. Pharmira Continuous Manufacturing in Pharmaceutical Products, Services and Solutions
Table 74. Revenue (US$ Million) in Continuous Manufacturing in Pharmaceutical Business of Pharmira (2019-2024)
Table 75. Pharmira Recent Developments
Table 76. SL Controls Basic Information List
Table 77. SL Controls Description and Business Overview
Table 78. SL Controls Continuous Manufacturing in Pharmaceutical Products, Services and Solutions
Table 79. Revenue (US$ Million) in Continuous Manufacturing in Pharmaceutical Business of SL Controls (2019-2024)
Table 80. SL Controls Recent Developments
Table 81. CONTINUUS Pharmaceuticals Basic Information List
Table 82. CONTINUUS Pharmaceuticals Description and Business Overview
Table 83. CONTINUUS Pharmaceuticals Continuous Manufacturing in Pharmaceutical Products, Services and Solutions
Table 84. Revenue (US$ Million) in Continuous Manufacturing in Pharmaceutical Business of CONTINUUS Pharmaceuticals (2019-2024)
Table 85. CONTINUUS Pharmaceuticals Recent Developments
Table 86. Hovione Basic Information List
Table 87. Hovione Description and Business Overview
Table 88. Hovione Continuous Manufacturing in Pharmaceutical Products, Services and Solutions
Table 89. Revenue (US$ Million) in Continuous Manufacturing in Pharmaceutical Business of Hovione (2019-2024)
Table 90. Hovione Recent Developments
Table 91. IMA Group Basic Information List
Table 92. IMA Group Description and Business Overview
Table 93. IMA Group Continuous Manufacturing in Pharmaceutical Products, Services and Solutions
Table 94. Revenue (US$ Million) in Continuous Manufacturing in Pharmaceutical Business of IMA Group (2019-2024)
Table 95. IMA Group Recent Developments
Table 96. Dec Group Basic Information List
Table 97. Dec Group Description and Business Overview
Table 98. Dec Group Continuous Manufacturing in Pharmaceutical Products, Services and Solutions
Table 99. Revenue (US$ Million) in Continuous Manufacturing in Pharmaceutical Business of Dec Group (2019-2024)
Table 100. Dec Group Recent Developments
Table 101. Key Raw Materials Lists
Table 102. Raw Materials Key Suppliers Lists
Table 103. Continuous Manufacturing in Pharmaceutical Downstream Customers
Table 104. Continuous Manufacturing in Pharmaceutical Distributors List
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Continuous Manufacturing in Pharmaceutical Product Picture
Figure 2. Global Continuous Manufacturing in Pharmaceutical Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Continuous Manufacturing in Pharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 4. Continuous Manufacturing in Pharmaceutical Report Years Considered
Figure 5. Global Continuous Manufacturing in Pharmaceutical Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Continuous Manufacturing in Pharmaceutical Revenue in 2023
Figure 7. Continuous Manufacturing in Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Powder Picture
Figure 9. Tablet Picture
Figure 10. Capsule Picture
Figure 11. Injection Picture
Figure 12. Others Picture
Figure 13. Global Continuous Manufacturing in Pharmaceutical Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Continuous Manufacturing in Pharmaceutical Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of In-house
Figure 16. Product Picture of CMO
Figure 17. Product Picture of CDMO
Figure 18. Global Continuous Manufacturing in Pharmaceutical Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Continuous Manufacturing in Pharmaceutical Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America Continuous Manufacturing in Pharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Continuous Manufacturing in Pharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe Continuous Manufacturing in Pharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Continuous Manufacturing in Pharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific Continuous Manufacturing in Pharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific Continuous Manufacturing in Pharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 26. South America Continuous Manufacturing in Pharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 27. South America Continuous Manufacturing in Pharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Continuous Manufacturing in Pharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Continuous Manufacturing in Pharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions Continuous Manufacturing in Pharmaceutical Sales Value (%), (2019-2030)
Figure 31. United States Continuous Manufacturing in Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States Continuous Manufacturing in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 33. United States Continuous Manufacturing in Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe Continuous Manufacturing in Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe Continuous Manufacturing in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe Continuous Manufacturing in Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 37. China Continuous Manufacturing in Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 38. China Continuous Manufacturing in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 39. China Continuous Manufacturing in Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan Continuous Manufacturing in Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan Continuous Manufacturing in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan Continuous Manufacturing in Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea Continuous Manufacturing in Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea Continuous Manufacturing in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea Continuous Manufacturing in Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia Continuous Manufacturing in Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Continuous Manufacturing in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia Continuous Manufacturing in Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 49. India Continuous Manufacturing in Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 50. India Continuous Manufacturing in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 51. India Continuous Manufacturing in Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 52. Continuous Manufacturing in Pharmaceutical Industrial Chain
Figure 53. Continuous Manufacturing in Pharmaceutical Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
